Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2021 | COVID-19 and IMW 2021

Noopur Raje • 11 Sep 2021
IMW 2021
General Multiple Myeloma

Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, briefly talks on the impact of COVID-19 on the 2021 International Myeloma Workshop and the steps that have been taken to ensure safety for the duration of the meeting. This interview took place during the 18th International Myeloma Workshop (IMW 2021) congress.

Disclosures

Noopur Raje, MD, has participated in consulting for Amgen, BMS, GSK, Janssen, Takeda, Oncopeptides, Karyopharm, Bluebird Bio, Pfizer, AstraZeneca; has participated in the advisory boards of Immuneel and Caribou; and has received research funding from Bluebird Bio,

More from Noopur Raje

2:06
Challenges with selecting therapy after failure of frontline treatments in R/R multiple myeloma
Noopur Raje • 29 Sep 2023
2:35
Recommendations for managing infections in patients with myeloma treated with bispecifics
Noopur Raje • 29 Sep 2023
1:13
The role of checkpoint inhibitors in multiple myeloma & future considerations for these agents
Noopur Raje • 29 Sep 2023
2:17
Session highlights: practical aspects of immunotherapy in multiple myeloma
Noopur Raje • 29 Sep 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals